Croma-Pharma

Croma-Pharma

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Croma-Pharma is a long-established, private Austrian medtech and aesthetics company with a global footprint. It focuses on minimally invasive treatments in ophthalmology, dermatology, and aesthetics, offering a trusted, single-source portfolio of products like dermal fillers and medical devices. The company leverages a family-owned structure for stability and invests significantly in professional education (cromacare) to drive adoption and loyalty. Its business model is commercial, generating revenue through B2B sales to medical practitioners.

OphthalmologyDermatologyAesthetic Medicine

Technology Platform

Expertise in formulation and manufacturing of biocompatible injectables (e.g., hyaluronic acid-based dermal fillers) and ophthalmic medical devices, supported by the integrated cromacare global education platform for practitioners.

Funding History

2
UndisclosedUndisclosed
UndisclosedUndisclosed

Opportunities

The global expansion of demand for minimally invasive aesthetic procedures, especially in emerging markets, presents a major growth avenue.
The increasing emphasis on practitioner training and safety protocols amplifies the value of its integrated cromacare educational platform, creating a strong customer retention tool.

Risk Factors

Intense competition from larger, resource-rich global players in the aesthetics space threatens market share.
Regulatory hurdles and the potential for adverse events with injectable products pose significant reputational and financial liabilities.

Competitive Landscape

Croma-Pharma competes in the crowded global medical aesthetics market against giants like AbbVie (Allergan), Galderma, and Merz Pharma, as well as numerous other specialized companies. Its differentiation relies on its family-owned, practitioner-focused approach, comprehensive product portfolio for core indications, and its dedicated cromacare education system.